Colon cancer blood test offers new screening option
Time:2024-05-21 08:17:25 Source:worldViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
Next:Red Lobster seeks bankruptcy protection after closing some restaurants
You may also like
- Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
- Bella Hadid goes braless in a thigh
- Minnesota Uber and Lyft driver pay package beats deadline to win approval in Legislature
- Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- With Djokovic awaiting the winner, Murray trails Hanfmann at rain
- Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
- College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
- ‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
- Kevin Pillar gets 1,000th career hit in Angels' win at Texas